Skip to main content
. 2015 Apr 27;10(4):e0124169. doi: 10.1371/journal.pone.0124169

Table 4. Occurrence of individual adverse events.

Adverse events (n) Grade 0 Grade 1 Grade 2 Grade 3
Alopecia 16 (34.0%) 12 (25.5%) 19 (40.4%) 0 (0%)
Nail ridging 42 (89.4%) 5 (10.5%) 0 (0%) 0 0%)
Dry skin 40 (85.1%) 7 (14.9%) 0 (0%) 0 (0%)
Nausea 35 (74.5%) 9 (19.1%) 3 (6.4%) 0 (0%)
Constipation 31 (66.0%) 12 (25.5%) 3 (6.4%) 1 (2.1%)
Mucositis oral 35 (74.5%) 10 (21.3%) 2 (4.3%) 0 (0%)
Oral pain 42 (89.4%) 5 (10.6%) 0 (0%) 0 0%)
Peripheral sensory neuropathy 38 (80.9%) 9 (19.1%) 0 (0%) 0 (0%)
Dysgeusia 39 (83.0%) 3 (6.4%) 5 (10.6%) 0 (0%)
Malaise 21 (44.7%) 19 (40.4%) 7 (14.9%) 0 0%)
Fever 40 (85.1%) 7 (14.9%) 0 (0%) 0 (0%)
White blood cell decreased 37 (78.7%) 8 (17.0%) 2 (4.3%) 0 (0%)
Anemia 29 (61.7%) 18 (38.3%) 0 (0%) 0 0%)
Anorexia 27 (57.4%) 9 (19.1%) 11 (23.4%) 0 (0%)